Zacks Investment Research upgraded shares of Monsanto Company (NYSE:MON) from a hold rating to a buy rating in a research report report published on Tuesday morning. They currently have $122.00 target price on the stock.
According to Zacks, “Over the last one month, Monsanto’s shares outperformed the Zacks categorized Agricultural/Products industry. The company reported better-than-expected first-quarter fiscal 2017 earnings. Monsanto expects to close Bayer’s buyout deal by the fall of fiscal 2017. This would likely boost Monsanto’s competency within the industry. Moreover, rising global population, greater market penetration of products and new innovations are anticipated to reinforce near-term results. Over the last 30 days, Zacks Consensus Estimate for the stock has been revised upwards for both fiscal 2017 and 2018.”
Several other research firms have also issued reports on MON. Piper Jaffray Companies set a $128.00 price objective on Monsanto Company and gave the company a buy rating in a research note on Thursday, September 15th. Sanford C. Bernstein reaffirmed a sell rating on shares of Monsanto Company in a research note on Thursday, September 15th. BMO Capital Markets set a $128.00 price objective on Monsanto Company and gave the company a buy rating in a research note on Thursday, September 15th. S&P Equity Research reaffirmed a positive rating on shares of Monsanto Company in a research note on Thursday, September 15th. Finally, Deutsche Bank AG raised their price objective on Monsanto Company from $118.00 to $128.00 and gave the company a buy rating in a research note on Thursday, September 15th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and seventeen have issued a buy rating to the stock. The stock presently has a consensus rating of Buy and an average target price of $114.46.
Monsanto Company (NYSE:MON) traded up 0.01% during trading on Tuesday, hitting $108.45. The stock had a trading volume of 1,137,554 shares. The stock has a 50 day moving average price of $104.83 and a 200-day moving average price of $103.81. The stock has a market cap of $47.56 billion, a price-to-earnings ratio of 29.74 and a beta of 1.01. Monsanto Company has a 12 month low of $83.73 and a 12 month high of $114.26.
Monsanto Company (NYSE:MON) last released its quarterly earnings results on Thursday, January 5th. The company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.20. The business earned $2.22 billion during the quarter. Monsanto Company had a return on equity of 47.05% and a net margin of 11.61%. The business’s quarterly revenue was up 19.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.11) EPS. On average, equities analysts predict that Monsanto Company will post $4.73 EPS for the current year.
TRADEMARK VIOLATION NOTICE: “Monsanto Company (MON) Upgraded to “Buy” by Zacks Investment Research” was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this report on another domain, it was stolen and reposted in violation of United States & international copyright law. The legal version of this report can be accessed at https://sportsperspectives.com/2017/01/11/monsanto-company-mon-upgraded-to-buy-by-zacks-investment-research.html.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 27th. Stockholders of record on Friday, January 6th will be paid a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 1.99%. The ex-dividend date of this dividend is Wednesday, January 4th. Monsanto Company’s payout ratio is currently 58.86%.
In other news, EVP Robert T. Fraley sold 80,631 shares of the stock in a transaction on Friday, October 14th. The stock was sold at an average price of $102.04, for a total value of $8,227,587.24. Following the sale, the executive vice president now directly owns 38,711 shares in the company, valued at $3,950,070.44. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Kerry J. Preete sold 2,745 shares of the stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $100.96, for a total value of $277,135.20. Following the completion of the sale, the executive vice president now owns 50,056 shares in the company, valued at $5,053,653.76. The disclosure for this sale can be found here. 0.79% of the stock is owned by insiders.
Several hedge funds have recently made changes to their positions in the stock. Mycio Wealth Partners LLC boosted its stake in shares of Monsanto Company by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in shares of Monsanto Company by 0.9% in the second quarter. Quadrant Capital Group LLC now owns 1,858 shares of the company’s stock valued at $184,000 after buying an additional 16 shares during the last quarter. Bradley Foster & Sargent Inc. CT boosted its stake in shares of Monsanto Company by 0.3% in the third quarter. Bradley Foster & Sargent Inc. CT now owns 5,838 shares of the company’s stock valued at $597,000 after buying an additional 18 shares during the last quarter. Advisor Partners LLC boosted its stake in shares of Monsanto Company by 0.4% in the second quarter. Advisor Partners LLC now owns 6,238 shares of the company’s stock valued at $645,000 after buying an additional 23 shares during the last quarter. Finally, Brinker Capital Inc. boosted its stake in shares of Monsanto Company by 0.5% in the second quarter. Brinker Capital Inc. now owns 5,741 shares of the company’s stock valued at $594,000 after buying an additional 30 shares during the last quarter. Institutional investors and hedge funds own 73.70% of the company’s stock.
Monsanto Company Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.